LI
Liminatus Pharma, Inc. Warrants (LIMNW)
NASDAQ·Healthcare·Biotechnology
$0.04
—
Mkt Cap $1.18M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$244.95
Range $166.14 – $287.55
Implied Upside
+612275.0%
Consensus $244.95 vs current $0.04